Susquehanna Portfolio Strategies »

C4 Therapeutics shares owned by Susquehanna Portfolio Strategies

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Susquehanna Portfolio Strategies from 13F filings

Historical chart of Susquehanna Portfolio Strategies investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Susquehanna Portfolio Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Susquehanna Portfolio Strategies

Quarter filed Position value Share count Share price at filing
2024-03-31 $745k 91k 8.17

More positions owned by Susquehanna Portfolio Strategies

Kenvue (KVUE)
Emcor (EME)
Lowe's Companies (LOW)
Amazon (AMZN)
Stryker Corporation (SYK)
Marathon Petroleum Corp (MPC)
Thermo Fisher Scientific (TMO)
Visa Com Cl A (V)
Merck & Co (MRK)
Morgan Stanley Com New (MS)
Union Pacific Corporation (UNP)
AutoZone (AZO)
Kinsale Cap Group (KNSL)
Goldman Sachs (GS)
ConocoPhillips (COP)

View all positions for Susquehanna Portfolio Strategies

Top funds holding C4 Therapeutics

RA Capital Management
Daniel D. Thurber
Lynx1 Capital Management
Commodore Capital
Vanguard Group
Soleus Capital Management
Balyasny Asset Management
T. Rowe Price Associates
Bank of America Corporation
Two Sigma Advisers
Arrowpoint Asset Management
Goldman Sachs Group
Two Sigma Investments
Bain Capital Life Sciences Investors
Susquehanna International

View all funds holding C4 Therapeutics